EDGAR Filing Documents for 0001062993-15-002351

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SEC Accession No. 0001062993-15-002351

Filing Date

2015-05-04

Accepted

2015-05-04 17:01:57

Documents

Period of Report

2014-12-02

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4a.html	4/A
1	AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	form4a.xml	4/A	3255
	Complete submission text file	0001062993-15-002351.txt		4604

Mailing Address 35 WILBUR STREET LYNBROOK NY 11563

Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000

BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4092 BOCAIRE BLVD. BOCA RATON FL 33487

Business Address

Type: 4/A | Act: 34 | File No.: 001-34236 | Film No.: 15829293